Investments - Equity Method Investments (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
Schedule of Equity Method Investments [Line Items] | |||||
Total assets | $ 261,022,511 | $ 261,022,511 | $ 245,126,650 | ||
Total liabilities | 65,910,052 | 65,910,052 | 82,564,514 | ||
DHCM’s portion of net assets | 82,338,692 | 82,338,692 | $ 94,023,248 | ||
Investment income | 14,554,685 | $ (654,591) | 15,674,654 | $ 8,711,087 | |
Net realized gains | 3,827,435 | 631,300 | 4,037,505 | 1,010,255 | |
Change in unrealized | 9,647,729 | $ (2,089,643) | 9,606,545 | $ 5,959,069 | |
DHCM’s portion of net income | 11,803,043 | 11,483,309 | |||
Equity Method Investment, Nonconsolidated Investee or Group of Investees | |||||
Schedule of Equity Method Investments [Line Items] | |||||
Total assets | 241,289,762 | 241,289,762 | |||
Total liabilities | 11,047,014 | 11,047,014 | |||
Net assets | 230,242,748 | 230,242,748 | |||
Investment income | 1,829,847 | 3,364,236 | |||
Expenses | 526,073 | 1,007,070 | |||
Net realized gains | 3,781,770 | 9,015,493 | |||
Change in unrealized | 21,050,372 | 18,020,448 | |||
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $ 26,135,916 | $ 29,393,107 |
X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|